This is the authors' abstract. We don't add key points for this paper.
The lack of effective and selective adsorbents for uranium (U(VI)) removal has become a growing concern in the nuclear industry. In this study, a novel uranyl-binding peptide was isolated from a phage-displayed random heptapeptide library through three rounds of biopanning. Sequence analysis revealed enrichment of basic and polar amino acids, including arginine and serine. One of the identified peptides, designated 7–5, was cloned into the yeast surface display vector pYD1 and expressed in Saccharomyces cerevisiae EBY100, generating the recombinant strain EBY100-7-5. Under optimal conditions (pH 4.73), the engineered strain exhibited a maximum U(VI) adsorption capacity of 79.33 ± 3.39 mg/g, representing a 22.69% increase compared to the control strain EBY100. The adsorption kinetics followed a pseudo-second-order model, and the equilibrium data were well described by the Freundlich isotherm. Thermodynamic analysis indicated that the adsorption process was spontaneous and endothermic. In the presence of 11 competing metal ions, EBY100-7-5 showed selective U(VI) adsorption, with significantly higher uptake for U(VI) than for other metal ions. Scanning electron microscopy combined with energy-dispersive X-ray spectroscopy (SEM-EDS) revealed particulate deposits and characteristic U(VI) signals on the cell surface after adsorption, confirming that the engineered yeast cells served as the primary active sites. Collectively, these results demonstrate that the uranyl-binding peptide confers high adsorption capacity, rapid kinetics, and strong selectivity to EBY100-7-5, presenting this engineered strain as a promising biosorbent for the efficient treatment of uranium-containing radioactive wastewater.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: